{"id":12435,"date":"2015-03-11T15:20:02","date_gmt":"2015-03-11T14:20:02","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=12435"},"modified":"2015-03-11T15:20:02","modified_gmt":"2015-03-11T14:20:02","slug":"el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","title":{"rendered":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments"},"content":{"rendered":"<p>L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria <b>incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients<\/b>, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de tot el territori nacional (7 catalanes) que han seguit i han avaluat a un total de 610 pacients.<\/p>\n<figure id=\"attachment_12436\" aria-describedby=\"caption-attachment-12436\" style=\"width: 328px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/03\/RIFAC1.jpg\"><img decoding=\"async\" class=\" wp-image-12436 \" alt=\"RIFAC1\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/03\/RIFAC1.jpg\" width=\"328\" height=\"141\" \/><\/a><figcaption id=\"caption-attachment-12436\" class=\"wp-caption-text\">L&#8217;actuaci\u00f3 del farmac\u00e8utic va produir un augment relatiu del 62,2% en la taxa de compliment del tractament per part del pacient, registrant un percentatge d&#8217;adher\u00e8ncia del 78,5% al final de l&#8217;estudi enfront del 48,4% de la visita inicial.<br \/>Font: Portalfarma (Consejo)<\/figcaption><\/figure>\n<p>Els resultats que s\u2019han obtingut a aquest estudi demostren que, en pacients que utilitzaven IBP, l&#8217;actuaci\u00f3 professional del farmac\u00e8utic des de <b>la farm\u00e0cia comunit\u00e0ria augmenta significativament el coneixement de la medicaci\u00f3 per part del pacient,<\/b> <b>el grau d&#8217;adher\u00e8ncia al tractament, aix\u00ed com una millora de la qualitat de vida dels pacients<\/b>.<\/p>\n<p>El COFB ha col\u00b7laborat en aquest estudi, que compta amb el suport dels laboratoris Cinfa.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.portalfarma.com\/Profesionales\/InvestigacionFarmacia\/Documents\/Estudio-sobre-conocimiento-adherencia-Inhibidores-Bomba-Protones.PDF\" target=\"_blank\" rel=\"noopener\"><div class=\"box shadow\"><span style=\"text-decoration: underline;\"><strong>Informe dels resultats de l\u2019Estudio IBP<\/strong> (PDF)<\/span><\/a><\/p>\n<p>Font i m\u00e9s informaci\u00f3: <span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.portalfarma.com\/Profesionales\/Notas-de-prensa\/Paginas\/La-actuacion-del-farmaceutico-desde-la-Farmacia-comunitaria-incrementa-adherencia-al-tratamiento-de-pacientes.aspx\" target=\"_blank\" rel=\"noopener\"><strong>nota de premsa<\/strong> Portalfarma<\/a><\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.portalfarma.com\/profesionales\/investigacionfarmacia\/Paginas\/Investigacion-en-Farmacia.aspx\"><strong>Investigaci\u00f3n en Farmacia Comunitaria Red de Investigaci\u00f3n en Farmacia Comunitaria \u2013 RIFAC<\/strong> (via Portalfrma)<\/a><\/span><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12447,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[2187,64,45],"class_list":["post-12435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-farmacia","tag-adherencia","tag-atencio-farmaceutica","tag-medicaments"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-11T14:20:02+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments\",\"datePublished\":\"2015-03-11T14:20:02+00:00\",\"dateModified\":\"2015-03-11T14:20:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"adher\u00e8ncia\",\"Atenci\u00f3 farmac\u00e8utica\",\"medicaments\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\",\"name\":\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-03-11T14:20:02+00:00\",\"dateModified\":\"2015-03-11T14:20:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","og_locale":"ca_ES","og_type":"article","og_title":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-03-11T14:20:02+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments","datePublished":"2015-03-11T14:20:02+00:00","dateModified":"2015-03-11T14:20:02+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage"},"thumbnailUrl":"","keywords":["adher\u00e8ncia","Atenci\u00f3 farmac\u00e8utica","medicaments"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","url":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","name":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-03-11T14:20:02+00:00","dateModified":"2015-03-11T14:20:02+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/12435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=12435"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/12435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=12435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=12435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=12435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}